Ashley Sloat Image

Ashley Sloat

Director of Patent Strategy

Aurora Consulting

Ashley is Director of Patent Strategy at Aurora Consulting and a USPTO-registered patent practitioner who specializes in the development and management of patent portfolios for startup ventures and emerging growth companies. As the owner and Director of Patent Strategy at Aurora Consulting LLC, Ashley has over 10 years of experience in patent application drafting and prosecution in a wide variety of technological areas including robotic systems, intracardiac devices, wireless healthcare technologies, physical activity equipment, biotechnologies, surgical training systems, topical drug formulations, drug repurposing, and other medical and consumer product devices. Aurora Consulting currently serves clients, ranging in size and technological field, throughout the U.S. and internationally.

Ashley earned her Ph.D. in the biomedical sciences from the University of Michigan. In addition to her research in immune-mediated disorders, Ashley also worked as a technology transfer fellow in the Office of Technology Transfer at the U of M. There she analyzed nascent technology for commercialization potential (marketability, challenges, competitors, potential licensees) and patentability. After earning her Ph.D., Ashley served as a patent infringement researcher for the U of M and a regulatory writer for an Ann Arbor-based, early stage pharmaceutical company, in particular, drafting documents for approval by the European Medicines Agency.

Recent Articles by Ashley Sloat

Patently Strategic Podcast: Prenuptial Patenting

You have your big idea and now it’s time to breathe it into existence, but you need some help with the development. Like many others, you may turn to the aid of an engineering firm or dev shop. This relationship is a marriage of sorts. But it’s a marriage that is designed to inevitably end in divorce. How cleanly, smoothly, and successfully this separation goes depends on the steps that you take before it officially begins. The end goals are a great product and clean asset separation. You’ll want your IP and any newly created devices, infrastructure, etc. – and the engineering firm will want to not be inhibited from doing their job with other clients going forward.

Patently Strategic Podcast: Fortifying Life Science Patents

The life sciences are currently facing at least two major plagues in our patent world. The first is that many life science innovations have been deemed ineligible in terms of patentable subject matter. In other words, the courts and the patent office believe that the patent laws are not meant to protect these innovations. The second plague is that the courts believe that many life science patents are not enabled. In other words, they are not described in sufficient detail to enable one of skill in the art to make and use the invention.